← Leaderboards
Connie Wu
Brigham And Women'S Hospital
$1,247,010
Attributed
$1,247,010
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $558.5K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,247,010 · 3
By mechanism
R35$742,292 · 1
R21$373,402 · 1
F32$131,316 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Steven Russell Barthel$2,531,097
- Tobias Schatton$4,457,299
- Charles J Dimitroff$9,730,798
- Vijay K Kuchroo$71,617,613
- Sophia Koo$15,534,982
Others in their field
Other Emerging Leaders on “Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$113,883,001
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
DesignTechnologyEngineeringRational DesignTherapeutic RnaIn VivoStructureFaceMolecularSingle MoleculeBenchmarkingImmune ResponseProteinsIn Vivo EvaluationSuccessCommunicable DiseasesDetectionBaseAgonistAcuteAreaBrain InjuriesAnti-Tumor Immune ResponseAdsorption
Grant awards (6)
Multidimensional approaches to understand and improve RNA therapeutic design and delivery$370,686
R35 · FY2025 · GM · contact PI
Programmable 'all-in-one' RNA as a molecular scaffold for targeted combinatorial innate immune activation$186,537
R21 · FY2025 · EB · contact PI
Multidimensional approaches to understand and improve RNA therapeutic design and delivery$371,606
R35 · FY2024 · GM · contact PI
Programmable 'all-in-one' RNA as a molecular scaffold for targeted combinatorial innate immune activation$186,865
R21 · FY2024 · EB · contact PI
Development of an Ultrasensitive Point-of-Care Salivary Diagnostic for Mild Traumatic Brain Injury$66,390
F32 · FY2021 · EB · contact PI
Development of an Ultrasensitive Point-of-Care Salivary Diagnostic for Mild Traumatic Brain Injury$64,926
F32 · FY2020 · EB · contact PI